ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Hany S. Attallah, Radwa M. Hamed, Haytham A. Abdelkader, Mahmoud M. Abdallah, Aliaa Mahmoud, Ibraheem Haggag, Bassam E. Makram, Ahmed M. El-Saeed
Radiation therapy after conservative breast surgery is an integral part of the treatment of early breast cancer . The aim of radiotherapy is to achieve the best coverage of the Planning Target Volume (PTV ), while reducing the dose to the Organs at Risk (OAR)…
Ana Sanz, Ruth Marín, Cristina Martínez, Penny Kechagiogliou, Escarlata López
Introduction: The health and assistance crisis generated by the SARS-CoV2 pandemic has been a serious health problem and a major disruption to the general population, specifically to the most vulnerable groups as cancer patients. This situation is forcing hea…
Hanna Sallinen, Vivi Rintanen, Leea Keski-Nisula, Maarit Anttila
Aim : Fundamentally, aggressive care is considered to be avoided for the patients at the end of life. However, this is not always adhered in real-world practice. We attempted to determine whether, and if so how, the aggressive care is made for patients with o…
A. Mounir, E. E. Ibrahim
Introduction: Epithelial Ovarian Carcinoma (EOC) comprises the vast majority (almost 90%) of ovarian carcinomas. Chemotherapy is the main treatment in ovarian cancers. The standard of care in the chemotherapeutic is the combination of a platinum (carboplatin…
Gael Kietga, Wilfried Mosse, Patricia Agbanglanon, Bertrand Compaore, Davy Nchepo, Evrard Seka, Sanae Elmajjaoui, Hanane Elkacemi, Tayeb Kebdani, Amine Lachgar, Noureddine Benjaafar
Introduction : To determine the proportion and the reasons which lead to palliative treatment in patients initially a candidate for concomitant chemoradiotherapy (CCRT). Methods : A retrospective study including patients followed for locally advanced lung can…
Joseph L. Blidgen, Patrice A. Pinkney
Lung cancer is the most common malignant tumor in men worldwide. It has been documented that patients can develop multiple primary lung cancer, with a 5% annual risk of a second primary (metachronous) cancer occurring after prior curative treatment. Moreover,…
Soumia Berrad, Zineb Benbrahim, Vincent Lorenga Kazadi, Lamiae Nouiakh, Hayat Erraichi, Rafik Naas, Lamiae Amaadour, Karima Oualla, Samia Arifi, Hinde El Fatemi, Nawfel Mellas
Metastatic small bowel tumors in the testes are uncommon often indicating an advanced stage of sickness with poor prognosis. The route of spread to the scrotal level has not yet been defined . The most of these tumors are diagnosed at autopsy or orchiectomy f…
Ola Røkke, Thomas Heggelund, Jūratė Šaltytė Benth, Marianne Steffensen Røkke, Kjell Øvrebø
Purpose: To identify clinical predictors for reduced long-term survival and describe the cause of death after surgical treatment for rectal cancer. Me thods: A retrospective follow-up study of 442 consecutive, unselected patients treated for rectal cancer at…
Juncheng Guo, Jinfang Zheng, Yijun Yang
Long - chain non - coding RNA HOXA11 antisense RNA (HOXA11 - AS) is a kind of lncRNA discovered in recent years. Long - chain non - coding RNA (LncRNA) is an important regulatory factor of protein - coding genes, especially the disorder of LncRNA in more and…
Dohoué Patricia Eliane Agbanglanon, Imane M’barki, Oswald Houessou, Gaël Kietga, Siham Jaba, Hafsa Elouazzani, Séka Evrard Narcisse, Hanan Elkacemi, Nadia Cherradi, Sanaa Elmajjaoui, Noureddine Benjaafar
Introduction : Rhabdomyosarcoma (RMS) is the most common soft tissue tumor in children, with the head and neck location accounting for up to 40% of cases. The embryonal and alveolar histologic variants are more commonly seen in pediatric patients. The treatme…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).